01Health, a London healthtech company, has raised £11.2M ($15M) in Series A funding to open up the clinical platform behind its dental brands and sell it to other practices. The round was led by Gresham House Ventures.
Existing backers Balderton Capital, Eka Ventures, and Wavemaker360 followed on, alongside angels including Blockchain.com co-founder Nicolas Cary.
01Health is the rebranded parent of 32Co, an orthodontics network, and Aerox Health, which works in dental sleep medicine. Both already run on its software. With the new name, the company is launching that platform as a standalone product for the first time, so practices and dental service organisations can licence it directly rather than going through 01Health’s own brands.
What 01Health is selling
The platform bundles clinical oversight, specialist protocols, workflow management, patient communication, and what the company calls ’01 Intelligence’, an AI layer for clinical work and patient acquisition. The pitch is that a local clinic can offer specialist treatment safely, with the protocols and supervision usually found only in hospitals or on Harley Street.
01Health was founded in 2022 by Dr Sonia Szamocki, a former NHS doctor and BCG consultant who is also chief executive. Its argument is that specialist care is bottlenecked because it sits in big hospitals and cities, while community clinics lack the systems to deliver it. The company says 90 per cent of the UK population now lives within 30 minutes of a dentist using its platform through 32Co, a figure it has not independently verified.
“Our mission is focused on enhancing accessibility to specialist care for communities that have been historically underserved,” Szamocki said.
The raise lands in a busy stretch for UK and European health tech. Investors have backed Rem3dy Health, clinical-documentation tools such as Ditto, and hospital-workflow AI such as Parallel. The common thread is software that tries to move care, or the admin around it, out of overloaded hospitals.
For now, 01Health is mostly a dental business. It has grown past 100 staff, and says trials are under way in clinical areas beyond dentistry, with platform trials also running in the United States, where it has hired a head of US commercial operations. The Series A will fund UK growth, the US push, and the public platform launch.
The open question is reach. Selling orthodontics workflows to dentists is one thing. Convincing other specialities, and their regulators, that a high-street clinic can safely deliver hospital-grade care on shared software is the harder claim this round is funding it to test.
Get the TNW newsletter
Get the most important tech news in your inbox each week.